BBH holdings — VanEck Biotech ETF
VanEck Biotech ETF (BBH) held 25 positions with net assets of $396M as of June 30, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 70.3% of the fund, led by AMGN, GILD, VRTX.
BBH top holdings
- AMGN Amgen Inc — 15.25% ($60.3M)
- GILD Gilead Sciences Inc — 12.79% ($50.6M)
- VRTX Vertex Pharmaceuticals Inc — 9.10% ($36.0M)
- REGN Regeneron Pharmaceuticals Inc — 6.21% ($24.6M)
- RVMD Revolution Medicines Inc — 5.27% ($20.9M)
- ARGX Argenx SE — 4.97% ($19.7M)
- NTRA Natera Inc — 4.92% ($19.5M)
- IQV IQVIA Holdings Inc — 4.31% ($17.0M)
- ALNY Alnylam Pharmaceuticals Inc — 3.83% ($15.2M)
- BIIB Biogen Inc — 3.63% ($14.3M)
- MRNA Moderna Inc — 3.36% ($13.3M)
- ILMN Illumina Inc — 3.17% ($12.5M)
- UTHR United Therapeutics Corp — 2.83% ($11.2M)
- ONC BeOne Medicines Ltd — 2.81% ($11.1M)
- INSM Insmed Inc — 2.67% ($10.6M)
- INCY Incyte Corp — 2.49% ($9.86M)
- NBIX Neurocrine Biosciences Inc — 2.08% ($8.24M)
- BNTX BioNTech SE — 1.94% ($7.68M)
- ICON PLC — 1.90% ($7.52M)
- TECH Bio-Techne Corp — 1.54% ($6.10M)
- CRL Charles River Laboratories International Inc — 1.50% ($5.94M)
- BMRN BioMarin Pharmaceutical Inc — 1.34% ($5.29M)
- QIAGEN NV — 1.06% ($4.21M)
- TEM Tempus AI Inc — 0.98% ($3.89M)
- State Street Global Advisors — 0.06% ($234K)
What are BBH's top 10 holdings?
AMGN (15.2%), GILD (12.8%), VRTX (9.1%), REGN (6.2%), RVMD (5.3%), ARGX (5.0%), NTRA (4.9%), IQV (4.3%), ALNY (3.8%), BIIB (3.6%).
How many stocks are in BBH?
VanEck Biotech ETF reported 25 holdings as of June 30, 2026.